Covington, Fenwick Shape $3B Deal For California Drugmaker
Japan's Astellas Pharma has agreed to pay roughly $3 billion for Audentes Therapeutics, a San Francisco-based drugmaker focused on treatments for rare neuromuscular conditions, the companies said Monday, in a deal...To view the full article, register now.
Already a subscriber? Click here to view full article